We are updating our Privacy Policy and Terms and Conditions to help you clearly understand how your personal information is collected, stored and managed. Learn More
Menu Back to Event-Details

New Collaboration Models with Regulators and Patients

How Can Better Outcomes Be Enabled by Big Data?

Day & Time:
April 18, 2:00PM - 3:15PM (Central Europe Standard Time)

Session Number:

Room Number:
Boston 3



New Collaboration Models with Regulators and Patients

Brian Mayhew, MA, MBA
Executive Director, Regulatory Policy
Novartis Pharmaceuticals Corporation, United States

This session will explore how the utilisation of advances in technology (such as big data, wearables, cloud computing) will open new opportunities & challenges for collaboration between companies with regulators, payers and patients: Is the present interaction model appropriate; should authorities be involved earlier in data collection & analysis, and how will this change patient engagement?

Presentation(s) & Speaker(s):
Impact of Digital Technology on Drug Development
Scott Askin
Digital Solutions Director
Novartis, Switzerland

Regulator Perspective on the Use of New Technology for Evidence Generation on Regulatory Decision Making
Alison Cave, PhD
Principal Scientific Administrator
European Medicines Agency (EMA), United Kingdom

Patient Perspective
Trishna Bharadia
Patient Advocate
-, United Kingdom